Gabalex Capital Management’s UnitedHealth UNH Stock Holding History

Gabalex Capital Management’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$10.1M	–	15
2022 Q3	$10.1M	Sell	20,000 -5,000	-20%	-$2.63M	5.57%	12
2022 Q2	$12.8M	Sell	25,000 -5,000	-17%	-$2.51M	7.45%	7
2022 Q1	$15.3M	Hold	30,000	–	–	7.05%	6
2021 Q4	$15.1M	Hold	30,000	–	–	6.4%	8
2021 Q3	$11.7M	Buy	30,000 +10,000	+50%	+$4.14M	5.42%	11
2021 Q2	$8.01M	Hold	20,000	–	–	3.77%	15
2021 Q1	$7.44M	Sell	20,000 -3,514	-15%	-$1.22M	3.76%	13
2020 Q4	$8.25M	Buy	23,514 +3,514	+18%	+$1.18M	4.46%	11
2020 Q3	$6.24M	Buy	+20,000	New	+$6.14M	1.75%	20

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gabalex Capital Management's UNH Position: Q4 2022 in Review

Gabalex Capital Management sold out of UnitedHealth (UNH) in Q4 2022, closing a stake of 20,000 shares — an estimated $10.1M sold.

Gabalex Capital Management first reported a position in UNH in Q3 2020 and held it in 9 quarters. The position peaked at $15.3M in Q1 2022. 3,157 funds tracked by Wall St. Rank hold UNH as of Q4 2022.

Gabalex Capital Management reported no remaining UnitedHealth position as of Q4 2022 after selling out during the quarter.
Gabalex Capital Management sold 20,000 UnitedHealth shares in Q4 2022, an estimated $10.1M.
Gabalex Capital Management first reported a position in UnitedHealth in Q3 2020 and held it in 9 quarters.
Gabalex Capital Management's UnitedHealth position peaked at $15.3M in Q1 2022.
3,157 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2022.

Based on Gabalex Capital Management's 13F filing for Q4 2022.